MedPath

Ciprofloxacin

Ciprofloxacin Ophthalmic Solution

Approved
Approval ID

5bc71138-98ef-49eb-822c-517550b397f8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2011

Manufacturers
FDA

H.J. Harkins Company, Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ciprofloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-557
Application NumberANDA076673
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ciprofloxacin
Product Specifications
Route of AdministrationOPHTHALMIC, TOPICAL
Effective DateDecember 21, 2011
FDA Product Classification

INGREDIENTS (9)

CIPROFLOXACIN HYDROCHLORIDEActive
Quantity: 3 mg in 1 mL
Code: 4BA73M5E37
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ciprofloxacin - FDA Drug Approval Details